Capvizr
THE DEAL, AT A GLANCE

Tempus

From the announcement
01What it doesThe new capital is framed around Expand AI to cardiology and build Tempus Hub clinical data exchange.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by SoftBank, VariousFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedTempus raised $275M Growth RoundFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersTempus is using Growth Round capital to extend an AI clinical intelligence and precision medicine platform from genomics, imaging, and clinical notes into cardiology and…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Tempus · Financing Record

Explore source-linked visual explanations for Tempus. Unsupported claims are withheld while source review continues.

Record 1008 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 1008 →

Open record 458 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime